Exponent, Inc. (NASDAQ:EXPO) Shares Purchased by Citigroup Inc.

Citigroup Inc. grew its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 174.7% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 48,309 shares of the business services provider’s stock after buying an additional 30,723 shares during the period. Citigroup Inc.’s holdings in Exponent were worth $5,569,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently made changes to their positions in EXPO. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of Exponent by 6.5% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after buying an additional 284,179 shares during the last quarter. Conestoga Capital Advisors LLC grew its stake in Exponent by 1.6% during the third quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider’s stock worth $323,535,000 after buying an additional 43,257 shares during the period. Geneva Capital Management LLC increased its holdings in Exponent by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after purchasing an additional 27,339 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Exponent by 0.6% in the second quarter. Dimensional Fund Advisors LP now owns 1,019,085 shares of the business services provider’s stock valued at $96,937,000 after acquiring an additional 6,108 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Exponent by 3.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 534,520 shares of the business services provider’s stock valued at $50,844,000 after purchasing an additional 17,849 shares in the last quarter. 92.37% of the stock is currently owned by hedge funds and other institutional investors.

Exponent Price Performance

Shares of EXPO stock opened at $98.71 on Monday. The company’s fifty day moving average price is $105.28 and its two-hundred day moving average price is $102.29. The firm has a market capitalization of $5.01 billion, a P/E ratio of 47.69 and a beta of 0.69. Exponent, Inc. has a 12 month low of $68.70 and a 12 month high of $115.75.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be issued a dividend of $0.28 per share. The ex-dividend date is Friday, December 6th. This represents a $1.12 annualized dividend and a yield of 1.13%. Exponent’s dividend payout ratio is presently 54.11%.

Insiders Place Their Bets

In other Exponent news, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the transaction, the director now directly owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Paul R. Johnston sold 14,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the completion of the sale, the director now owns 80,742 shares in the company, valued at $8,445,613.20. The trade was a 14.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,339 shares of company stock valued at $3,103,065 in the last ninety days. Corporate insiders own 2.10% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.